<DOC>
	<DOCNO>NCT02013271</DOCNO>
	<brief_summary>To demonstrate efficacy safety Lutonix® Drug Coated Balloon treatment long TASC II Class C D lesion ( ≥ 14 cm ) lesion SFA</brief_summary>
	<brief_title>Lutonix® DCB Treatment Long Lesions Femoropopliteal Arteries</brief_title>
	<detailed_description />
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Clinical Criteria 1 . ≥ 18 year age ; 2 . Rutherford Clinical Category 24 ; 3 . Subject legally competent voluntarily agree participation study 's provision ; willing provide 5year informed consent ; 4 . ≥ 70 % stenosis native femoropopliteal artery ( visual estimate ) amenable DCB without stenting ; 5 . TASC II Class C D Lesions intend target lesion treatment segment ( ) cumulatively ≥14 cm length ; 6. de novo lesion ( ) nonstented restenotic lesion ( ) &gt; 90 day prior angioplasty procedure ; 7 . Target vessel diameter ≥ 4 ≤ 7 mm ; 8 . Successful wire cross lesion predilatation ; 9 . No prior vascular intervention ( include contralateral limb ) within 2 week and/or plan 30 day protocol treatment . 1 . Women pregnant , lactating , plan become pregnant men intend father child ; 2 . Patient contraindicate use Lutonix Drug Coated Balloon per current Instructions For Use ( IFU ) ; 3 . Life expectancy &lt; 1year ; 4 . Patient currently participate investigational drug device study previously enrol study ; 5 . History stroke within 3 month ; 6 . History myocardial infarction , thrombolysis angina within 2 week enrollment ; 7 . Prior vascular surgery index limb exception endarterectomy remote common femoral patch angioplasty ; 8 . Target lesion involve previously place stent ; 9 . Inability take require study medication allergy contrast adequately manage pre postprocedure medication ; 10 . Significant inflow disease ; 11 . Known inadequate distal outflow plan future treatment vascular disease ; 12 . Sudden symptom onset , acute vessel occlusion , acute subacute angiographically visible thrombus target vessel ; 13 . Use adjunctive treatment modality ( e.g . laser , atherectomy cryoplasty )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>